Decera Clinical Education Medical Specialties Podcast

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including: Importance of moving beyond a glucose-centric approach to T2D care  Current evidence for incretin-based therapies in T2D Rationale for integrating these therapies into the primary care sett...

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.  Topics covered include: Treatment Goals Long-term Data With PPAR Agonists Investigational Therapies for Pruritus Presenter :  Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief,...

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including: The Lancet Commission’s new obesity definitions and diagnostic criteria Key data on incretin-based antiobesity medications like semaglutide and tirzepatide Best practices for p...

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBC Nonpharmacologic treatment options An overview of clinical t...

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBC  An overview of clinical trial data supporting second-line agent...

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment response Risk factors in PBC Biochemical treatment response and fibrosis stage as predictors of transplant-f...

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies.  Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Beth Is...

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN,  how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include: The Canadian PBC Society Survey: Comorbidities and Treatment Goals Defining and Achieving Goal-Dri...

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include:  Methods of Assessing PBC Disease Progression Newer Agents for Second-line Treatment of PBC Prioritizing Symptom Man...

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies. Presenter Peter Dicpinigaitis, MD Professor of Medicine Albert Einstein College of Medicine Division of Critical Care Medicine Montefiore Medical Center Director,...

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case. Presenter Michael S. Benninger, MD Professor of Otolaryngology-Head and Neck Surgery Lerner College of Medicine The Cleveland Clinic President, International Association of Phonosurgery Cleveland, Ohio Link to full pr...

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:  Documenting obesity as a diagnosis for patients with diabetes when appropriate Streamlining processes to ensure patients return for follow-up Dedicating a care manager to initiate patient outreach Impleme...

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include: Steatotic liver disease and PBC Vibration-controlled transient elastography (VCTE) and discordant biochemical respons...

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including: Patient candidacy considerations Treatment advancement strategies that go beyond topical therapies The importance of patient-centered care that address patients’ fears and needs A detailed patient cas...

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including: The available biologic therapies that specifically target IL-13 Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm How these agents compare to other AD therapies like...

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including: The information to collect during patient visits The available resources to help you submit prior authorizations The supporting documents that are often necessary to accompany prior author...

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including: Contributors to epidermal barrier dysfunction (eg, environmental triggers) IL-13 as a key cytokine in AD pathogenesis Targeted AD therapies that inhibit IL-13 A detailed patient case to highlight take-home points Presenter Andrew F. Alexis, MD...

In this podcast, Anne E. O’Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis bronchiectasis (NCFBE), including: Airway clearance as a foundation of NCFBE management Strategies to address inflammation and exacerbations Emerging therapies in clinical development How to individualize treatment to NCFBE phenotypes and endotypes Presenter Anne E....

In this podcast, Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure (HF) with mildly reduced or preserved ejection fraction, including: The emerging role of mineralocorticoid receptor antagonists in HF care Finerenone’s efficacy in reducing composite cardiovascular death and worsening HF events  Why...

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and...

Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, including Discussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can help Meeting patients where they are at and offering slow, incremental changes that...

Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough. Presenter Michael S. Blaiss, MD Clinical Professor of Pediatrics Division of Allergy-Immunology Medical College of Georgia at Augusta University Augusta, Georgia Link to full program:  htt...

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including: Why early detection is key for improving patient outcomes How to monitor through use of noninvasive imaging and biopsy per guideline recommendations How to coordinate patient care to...

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sejal Desai, MD, DABOM, to learn about how she implemented virtual support groups to improve obesity care at her practice, including: Dedicating 5 support groups with chat features to obesity-specific topics (eg, sleep, nonscale wins) Moderating these chats to ensure no misinformation is shared and a positive, safe space is maintained Expanding to...

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sophia Kwon, MD, to learn about how she implemented a documentation shortcut at her institution to improve obesity care, including: Creating an obesity checklist within the electronic health record Training staff to correctly use this checklist and broach obesity topics with patients Garnering feedback to ensure this checklist did not add to note f...